Article

Tolle leads WaveLight's U.S. operations as CEO

Sterling, VA-Wolfgang Tolle has been appointed as the new chief executive officer (CEO) of U.S. operations for WaveLight Inc., a subsidiary of WaveLight AG. In his new post, Tolle will assume responsibility for all business activities at the U.S. based-subsidiary and will report to WaveLight AG's CEO Max Reindl.

Sterling, VA-Wolfgang Tolle has been appointed as the new chief executive officer (CEO) of U.S. operations for WaveLight Inc., a subsidiary of WaveLight AG. In his new post, Tolle will assume responsibility for all business activities at the U.S. based-subsidiary and will report to WaveLight AG's CEO Max Reindl.

Most recently, Tolle was CEO of Launchdreams, a company that specializes in helping international enterprises become established and grow in the United States.

In addition, Tolle has held numerous other executive positions, including CEO, vice president of customer service, and chief technology officer at Cyveillance; president of Virginia's Center for Innovative Technology; and as president of the U.S. office of the German National Research Center for Computer Science.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.